Glycoprotein CD98 as a receptor for colitis-targeted delivery of nanoparticles
- 7 January 2014
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 2 (11) , 1499-1508
Abstract
Treatment strategies for inflammatory bowel disease have been constrained by limited therapeutic efficacy and serious adverse effects owing to a lack of receptors for targeted drug delivery to the inflamed colon. Upon inflammation, CD98 expression is highly elevated in colonic epithelial cells and infiltrating immune cells. To investigate whether CD98 can be used as a colitis-targeted delivery receptor, we constructed CD98 Fab′-bearing quantum dot (QD)-loaded nanoparticles (Fab′-NPs). The resultant Fab′-NPs had desired particle size (∼458 nm) with a narrow size distribution and zeta-potential (approximately +19 mV), low cytotoxicity, and excellent fluorescence properties. Electron microscopy images provided direct evidence for the well-dispersed distribution of QDs within spherical Fab′-NPs. Cellular uptake experiments demonstrated that Fab′-NPs were efficiently internalized into Colon-26 and RAW 264.7 cells through the CD98-mediated endocytosis pathway, and showed that the targeting effect of CD98 Fab′ markedly increased their cellular uptake efficiency compared with that of control pegylated QD-loaded NPs (PEG-NPs). Furthermore, ex vivo studies showed much more effective accumulation of Fab′-NPs in colitis tissue than that of PEG-NPs. These findings suggest that because of inflammation-dependent over-expression of CD98, active colitis-targeted delivery can be accomplished using NPs decorated with CD98 antibody.Keywords
This publication has 41 references indexed in Scilit:
- Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tractAdvanced Drug Delivery Reviews, 2013
- Targeted Inhibition of Serotonin Type 7 (5-HT7) Receptor Function Modulates Immune Responses and Reduces the Severity of Intestinal InflammationThe Journal of Immunology, 2013
- Biomedical applications of biodegradable polymersJournal of Polymer Science Part B: Polymer Physics, 2011
- CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in miceJournal of Clinical Investigation, 2011
- Nanonization strategies for poorly water-soluble drugsDrug Discovery Today, 2011
- Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel diseaseJournal of Controlled Release, 2011
- MicroRNA-7 Modulates CD98 Expression during Intestinal Epithelial Cell DifferentiationJournal of Biological Chemistry, 2010
- Poly(ω-pentadecalactone-co-butylene-co-succinate) nanoparticles as biodegradable carriers for camptothecin deliveryBiomaterials, 2009
- Addressing the PEG Mucoadhesivity Paradox to Engineer Nanoparticles that “Slip” through the Human Mucus BarrierAngewandte Chemie International Edition, 2008
- The nuclear pore complex: nucleocytoplasmic transport and beyondNature Reviews Molecular Cell Biology, 2003